Nephrogenic Diabetes Insipidus Associated with Foscarnet Treatment of Cytomegalovirus Retinitis
- 15 June 1990
- journal article
- case report
- Published by American College of Physicians in Annals of Internal Medicine
- Vol. 112 (12) , 955-956
- https://doi.org/10.7326/0003-4819-112-12-955
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Diagnosis of Diabetes insipidusPublished by S. Karger AG ,2015
- Pharmacokinetics of foscarnet and distribution to cerebrospinal fluid after intravenous infusion in patients with human immunodeficiency virus infectionAntimicrobial Agents and Chemotherapy, 1989
- Foscarnet treatment of cytomegalovirus retinitis in patients with the acquired immunodeficiency syndromeAntimicrobial Agents and Chemotherapy, 1989
- Treatment of Cytomegalovirus Retinitis with Trisodium Phosphonoformate Hexahydrate (Foscarnet)The Journal of Infectious Diseases, 1988
- Inhibition of human renal epithelial Na+/Pi cotransport by phosphonoformic acidBiochemical and Biophysical Research Communications, 1986
- Pharmacokinetics, safety and preliminary clinical experiences using foscarnet in the treatment of cytomegalovirus infections in bone marrow and renal transplant recipientsJournal of Antimicrobial Chemotherapy, 1986
- Intravenous Foscarnet for the Treatment of Severe Cytomegalovirus Infection in Allograft RecipientsScandinavian Journal of Infectious Diseases, 1985
- Drug-induced states of nephrogenic diabetes insipidusKidney International, 1976
- Recognition of Partial Defects in Antidiuretic Hormone SecretionAnnals of Internal Medicine, 1970